Company Monitoring Page for JNJ

latest headlines for company on cafepharma

Johnson & Johnson: Third Time’s Not the Charm for Expanded Xarelto Approval
Wall St Cheat Sheet
Mon, 01/20/14 - 11:11 am
Tags:
JNJ, Xarelto, bloodthinners, FDA
J&J Continues ‘Strategic Pruning’ With This Divestiture
Wall St Cheat Sheet
Fri, 01/17/14 - 08:40 am
Tags:
JNJ, diagnostics, Ortho Clinical Diagnostics, Carlyle
FDA advisory panel rejects J&J drug for acute coronary syndrome
Reuters
Thu, 01/16/14 - 04:54 pm
Tags:
JNJ, acute coronary syndrome, Xarelto, advisory panels, FDA
Key Pharmaceutical Stocks Ready to Deliver Earnings Beats
Yahoo/Zacks.com
Thu, 01/16/14 - 11:44 am
Tags:
earnings, Forest Labs, JNJ, Ironwood
The Carlyle Group Agrees to Acquire Johnson & Johnson’s Ortho-Clinical Diagnostics for $4.15 Billion
Marketwatch
Thu, 01/16/14 - 08:38 am
Tags:
JNJ, Carlyle, Ortho Clinical Diagnostics, diagnostics, M&A
J&J Said to Agree to Sell Ortho Unit to Carlyle for $4 Billion
Bloomberg
Wed, 01/15/14 - 05:27 pm
Tags:
JNJ, M&A, diagnostics, Ortho Clinical Diagnostics, Carlyle
FDA staff cautious about J&J's latest Xarelto application
Yahoo/Reuters
Tue, 01/14/14 - 09:26 am
Tags:
FDA, JNJ, Xarelto
China pulls J&J trademark on OneTouch diabetes products
Fierce Pharma
Fri, 01/10/14 - 08:36 am
Tags:
diabetes, China, JNJ, OneTouch, trademark
M&A Boom Seen in 2014 as Drug Hunt Spurs Biotech Deals
Bloomberg
Fri, 01/10/14 - 08:25 am
Tags:
M&A, biotech, generics, Merck, Bristol-Myers Squibb, General Electric, Gilead Sciences, Thermo Fisher, Forest Labs, FDA, Acorda Therapeutics, Pfizer, JNJ, Roche, Pharmacyclics
J&J petitions FDA to require "similar" names for biosimilars, biologics
Yahoo/Reuters
Thu, 01/9/14 - 08:30 am
Tags:
JNJ, FDA, biosimilars, Mylan, Novartis
Novadaq's Story Continues To Come Along
Seeking Alpha
Wed, 01/8/14 - 04:17 pm
Tags:
Novadaq Technologies, devices, Covidien, JNJ, Intuitive Surgical
J&J Innovation launches a discovery pact with fledgling upstart Scholar Rock
Fierce Biotech
Wed, 01/8/14 - 09:39 am
Tags:
Scholar Rock, JNJ Innovation, JNJ, autoimmune disease
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
Tags:
JNJ, Medivation, prostatce cancer, Astellas, Dendreon, Sanofi, Zytiga, Xtandi, Provenge
Pharmacyclics Shares Rise on Positive Leukemia Trial
Bloomberg
Tue, 01/7/14 - 11:49 am
Tags:
Pharmacyclics, JNJ, Imbruvica, chronic lymphocytic leukemia
Pluristem's Positive Data Could Open Massive Muscle Injury Market
Seeking Alpha
Tue, 01/7/14 - 09:24 am
Tags:
Pluristem Therapeutics, Stryker, JNJ, Zimmer, hip recall, PLX cell therapy
J&J's Synthes wins round in spat with ex-sales rep
Mass Device
Mon, 01/6/14 - 11:05 am
Tags:
devices, JNJ, Synthes
J&J gambles $12.5M in rare Big Pharma bet on a stem cell therapy
Fierce Biotech
Mon, 01/6/14 - 09:49 am
Tags:
JNJ, stem cells, Capricor
Tetraphase Pharmaceuticals: A Small Cap With Big Potential
Seeking Alpha
Sat, 01/4/14 - 04:14 pm
Tags:
Tetraphase Pharmaceuticals, AstraZeneca, Cubist Pharmaceuticals, antiobiotics, Eravacycline, JNJ, Merck, Pfizer
Pharmacyclics: As Imbruvica Commercialization Begins, Sell-Off Creates Opportunity
Seeking Alpha
Fri, 01/3/14 - 11:56 am
Tags:
Pharmacyclics, Imbruvica, JNJ, Roche, Celgene, Gilead Sciences, mantle cell lymphoma
Johnson & Johnson Seeking Higher Profits
Seeking Alpha
Thu, 01/2/14 - 11:18 am
Tags:
JNJ, diagnostics, M&A, Carlyle

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.